Cellular pharmacology and antitumor activity of N-(p-azidobenzoyl)-daunorubicin, a photoactive anthracycline analogue

[1]  R. L. Felsted,et al.  Rat heart anthracycline-binding polypeptides identified by photoaffinity labeling. , 1986, Molecular Pharmacology.

[2]  T. Tsuruo,et al.  High calcium content of pleiotropic drug-resistant P388 and K562 leukemia and Chinese hamster ovary cells. , 1984, Cancer research.

[3]  J. Fedan,et al.  Photoaffinity labels as pharmacological tools. , 1984, Biochemical pharmacology.

[4]  F. Arcamone.  Antitumor anthracyclines: Recent developments , 1984, Medicinal research reviews.

[5]  M. Broggini,et al.  Subcellular distribution of adriamycin in the liver and tumor of 3LL-bearing mice. , 1983, European journal of cancer & clinical oncology.

[6]  E. Goormaghtigh,et al.  Mitochondrial membrane modifications induced by adriamycin-mediated electron transport. , 1983, Biochemical pharmacology.

[7]  M. Israel,et al.  Effect of N-trifluoroacetyladriamycin-14-valerate on [3H]thymidine uptake and DNA synthesis of human lymphoma cells. , 1983, The Journal of biological chemistry.

[8]  A. Sartorelli,et al.  The role of membranes in the mechanism of action of the antineoplastic agent adriamycin. Spin-labeling studies with chronically hypoxic and drug-resistant tumor cells. , 1983, The Journal of biological chemistry.

[9]  R. Friedman,et al.  Nuclear catalyzed antibiotic free radical formation. , 1982, Cancer research.

[10]  R. Ganapathi,et al.  Comparative effects of adriamycin and N-trifluoroacetyladriamycin-14-valerate on cell kinetics, chromosomal damage, and macromolecular synthesis in vitro. , 1981, Cancer research.

[11]  N. Bachur,et al.  Cytofluorescence localization of anthracycline antibiotics. , 1980, Cancer research.

[12]  G. Aubel-Sadron,et al.  Subcellular localization of some anthracycline derivatives in Ehrlich ascites tumor cells. , 1980, Biochemical and biophysical research communications.

[13]  N. Bachur,et al.  Cellular pharmacology of N,N-dimethyl daunorubicin and N,N-dimethyl adriamycin. , 1980, Cancer research.

[14]  N. Bachur,et al.  Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography. , 1980, Drug metabolism and disposition: the biological fate of chemicals.

[15]  D. Kessel.  Biologic properties of three anthracyclines as a function of lipophilicity. , 1979, Biochemical pharmacology.

[16]  A. Trouet,et al.  Transport and storage of daunorubicin and doxorubicin in cultured fibroblasts. , 1978, Cancer research.

[17]  D. Henry,et al.  Synthetic approaches to adriamycin. 2. Degradation of daunorubicin to a nonasymmetric tetracyclic ketone and refunctionalization of the A ring to adriamycin. , 1977, The Journal of organic chemistry.

[18]  N. Bachur,et al.  Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation. , 1977, Molecular pharmacology.

[19]  N. Bachur,et al.  Daunorubicin metabolites in human urine. , 1975, The Journal of pharmacology and experimental therapeutics.

[20]  R. L. Felsted,et al.  Purification of the phytohemagglutinin family of proteins from red kidney beans (Phaseolus vulgaris) by affinity chromatography. , 1975, Biochimica et biophysica acta.

[21]  R. L. Felsted,et al.  Rat liver daunorubicin reductase. An aldo-keto reductase. , 1974, The Journal of biological chemistry.

[22]  A. Goldin,et al.  Comparison of the antileukemic effect in mice of adriamycin (NSC-123127) with daunomycin (NSC-82151). , 1970, Cancer chemotherapy reports.

[23]  A. Trouet,et al.  Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells , 2004, Cancer Chemotherapy and Pharmacology.

[24]  M. Weiner,et al.  Characterization of an anthracycline binding protein from mouse liver. Abstr. , 1983 .

[25]  V. Chowdhry,et al.  Photoaffinity labeling of biological systems. , 1979, Annual review of biochemistry.